157 related articles for article (PubMed ID: 33334860)
21. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
22. A Crucial Role of ACBD3 Required for Coxsackievirus Infection in Animal Model Developed by AAV-Mediated CRISPR Genome Editing Technique.
Shin HJ; Ku KB; Kim S; Kim HS; Kim YS; Kim BT; Kim SJ; Kim C
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546322
[TBL] [Abstract][Full Text] [Related]
23. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
[TBL] [Abstract][Full Text] [Related]
24. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
25. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
26. Efficient CRISPR/Cas9 Gene Editing in Uncultured Naive Mouse T Cells for In Vivo Studies.
NĂ¼ssing S; House IG; Kearney CJ; Chen AXY; Vervoort SJ; Beavis PA; Oliaro J; Johnstone RW; Trapani JA; Parish IA
J Immunol; 2020 Apr; 204(8):2308-2315. PubMed ID: 32152070
[TBL] [Abstract][Full Text] [Related]
27. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
28. Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research.
Eun K; Park MG; Jeong YW; Jeong YI; Hyun SH; Hwang WS; Kim SH; Kim H
BMC Biotechnol; 2019 Jan; 19(1):1. PubMed ID: 30606176
[TBL] [Abstract][Full Text] [Related]
29. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
30. CRISPR Gene Therapy of the Eye: Targeted Knockout of Vegfa in Mouse Retina by Lentiviral Delivery.
Holmgaard A; Alsing S; Askou AL; Corydon TJ
Methods Mol Biol; 2019; 1961():307-328. PubMed ID: 30912054
[TBL] [Abstract][Full Text] [Related]
31. Supernova: A Versatile Vector System for Single-Cell Labeling and Gene Function Studies in vivo.
Luo W; Mizuno H; Iwata R; Nakazawa S; Yasuda K; Itohara S; Iwasato T
Sci Rep; 2016 Oct; 6():35747. PubMed ID: 27775045
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
33. CRISPR/Cas9: at the cutting edge of hepatology.
Pankowicz FP; Jarrett KE; Lagor WR; Bissig KD
Gut; 2017 Jul; 66(7):1329-1340. PubMed ID: 28487442
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cpf1: A New Tool for Plant Genome Editing.
Zaidi SS; Mahfouz MM; Mansoor S
Trends Plant Sci; 2017 Jul; 22(7):550-553. PubMed ID: 28532598
[TBL] [Abstract][Full Text] [Related]
35. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
36. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
Song M
Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
Liu W; Yang C; Liu Y; Jiang G
Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-READI: Efficient Generation of Knockin Mice by CRISPR RNP Electroporation and AAV Donor Infection.
Chen S; Sun S; Moonen D; Lee C; Lee AY; Schaffer DV; He L
Cell Rep; 2019 Jun; 27(13):3780-3789.e4. PubMed ID: 31242412
[TBL] [Abstract][Full Text] [Related]
39. Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity.
Yang MG; West AE
Yale J Biol Med; 2016 Dec; 89(4):457-470. PubMed ID: 28018138
[TBL] [Abstract][Full Text] [Related]
40. Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System.
Shinohara Y; Konno A; Nitta K; Matsuzaki Y; Yasui H; Suwa J; Hiromura K; Hirai H
Mol Neurobiol; 2019 Jun; 56(6):4203-4214. PubMed ID: 30291583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]